Executive Vice President,
Bussiness Development
Applied Molecular Evolution
Montenegro
Mr. Kevin R. Lind has been the Chief Financial Officer and Executive Vice President at Arena Pharmaceuticals, Inc. since June 15, 2016. Mr. Lind served as the Principal Accounting Officer at Arena Pharmaceuticals, Inc. since August 10, 2016. He has with over 15 years of experience in healthcare banking and private equity. Mr. Lind is lead underwriter of TOP’s Life Sciences structured investments and drug royalty monetizations effort. Mr. Lind was the Vice President at TPG Biotech. Prior to Arena, Mr. Lind was at TPG, as a Principal at TPG Special Situations Partners and initially at TPG-Axon'sPharma Partners group.
Business Management